CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-06 | Hamill Laura Director | Grant or award · Stock Option (right to buy) | +10,600 | 10,600 | ||
| 2023-01-06 | Hamill Laura Director | Grant or award · Restricted Stock Unit | +3,900 | 3,900 | ||
| 2022-02-10 | Hamill Laura Director | Grant or award · Stock Option (right to buy) | +9,200 | 9,200 | ||
| 2021-02-10 | Hamill Laura Director | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2020-02-12 | Hamill Laura Director | Grant or award · Director Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2019-09-24 | Hamill Laura Director | Grant or award · Director Stock Option (Rigth to Buy) | +6,000 | 6,000 | ||
| 2019-09-24 | Hamill Laura Director | Grant or award · Director Stock Option (Right to Buy) | +2,268 | 2,268 |
Page 1 of 1 · 7 trades